FDA Inspections, 483’s & Warning Letters How to Avoid and Survive Them
FDA Inspections, 483's & Warning Letters
How to Avoid and Survive Them
Elizabeth L. Hohmann MD Physician Director, Partners IRBs
Sarah A. White MPH Director, Partners QI Program
June 12, 2017
1
Outline
? Overview ? FDA Inspection Process ? Case Studies from FDA 483s & Warning
Letters
? Clinical Investigators ? IRBs
2
FDA Authority
? Authority derived from 21 CFR 312, 812 ? Biomedical Research Monitoring Programming (BIMO),
established in 1977
? Objectives
? To protect the rights, safety, and welfare of subjects involved in FDA-regulated clinical trials;
? To verify the quality and integrity of the research data ? To assess compliance with FDA's regulations governing the
conduct of clinical trials.
3
BIMO Inspections
? Inspection assignments issued by Center to District Office
FDA
? Types of inspections
? Routine/Surveillance
? For Cause
? Announced vs. unannounced inspections
? Compliance Programs
? Clinical Investigators
? Institutional Review Boards
? Sponsors, Monitors & Contract Research Organization
? In-vivo Bioequivalence facilities
? Good Laboratory Practice (Non-Clinical Laboratories)
4
Why would you be inspected?
? Routine inspection:
? Clinical Investigator - verify data submitted to the FDA ? FDA is interested in what you're doing ? IRB: Every 5 years
? For-cause/Directed
? FDA receives information that calls into question study conduct or IRB practices
? Can be limited to one area of concern or cover entire study/ compliance program
5
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- laboratory audit preparation including review of fda warning letters
- warning letter federal trade commission
- warning letter
- fda warning letters research
- warning letters close out letters lachman consultant services inc
- cber 20 06 warning letter federal trade commission
- lessons learned in resolving fda warning letters microsoft
- fda warning letters what can we learn from them
- the emergency guide to fda warning letters fda 483 the fda group
- fda inspections 483 s warning letters how to avoid and survive them
Related searches
- how to avoid taxes on 401k withdrawal
- how to avoid dealer fees
- how to avoid disposition fee
- how to avoid plagiarism online
- how to avoid using i
- how to avoid plagiarism checker
- how to avoid autoimmune disease
- how to avoid mean people
- how to avoid foreign transaction fees
- how to avoid mortgage insurance
- how to avoid virus infections
- how to avoid someone